Insider Profile
Smith, Stephen A.
2
Companies Filed At
1
Open-Market Buys (2yr)
$14K
Buy Value (2yr, open-market)
Oct 28, 2025
Most Recent Trade
28
Credibility
Score
57%
Hit Rate
+41.7%
Avg 90d Return
+4.6%
Median 90d Return
7
Evaluated Trades
+183.5%
Best Trade
-21.1%
Worst Trade
Hit rate and returns are based on 7 open-market buys with evaluable 90-day outcomes. Score reflects historical conviction, not a guarantee of future performance. Limited signal — either below-average timing or insufficient trade history.
Cross-Company Track Record
THIN HISTORY
100%
Hit Rate · 90d
+30.3%
Median Alpha · 90d
1
Closed Buys Evaluated
100%
Beat XIU
All-insider base rate: 59% hit rate  · +1.3% mean alpha (n=11504)
size concentrated
Entry: closing price on SEDI filing date (point-in-time). Exit: 90 calendar days later. Alpha vs XIU.TO (iShares TSX 60). Closed trades only. Not investment advice.
Research 1 closed buys with individual return outcomes available on the Research plan.
Date Company Role Nature Dir. Shares Price Value Score
Oct 28, 2025 $OGI
Organigram Holdings
Comp. Grant Buy 45,081 70
Apr 04, 2025 $OGI
Organigram Holdings
Open Market Buy 10,000 $1.36 $14K 70
Oct 28, 2024 $OGI
Organigram Holdings
Comp. Grant Buy 39,566 $2.54 $100K 70
May 21, 2024 $OGI
Organigram Holdings
Comp. Grant Buy 7,575 $2.64 $20K 70
Dec 21, 2023 $OGI
Organigram Holdings
Comp. Grant Buy 62,213 $1.75 $109K 70
Dec 01, 2023 $WPR
CANPR Technology LTD.
Other Sell 55
Jul 05, 2023 $OGI
Organigram Holdings
Corp. Event Sell 7,725 70
Jul 05, 2023 $OGI
Organigram Holdings
Corp. Event Sell 60,000 70
Jul 05, 2023 $OGI
Organigram Holdings
Corp. Event Sell 124,352 70
Sep 29, 2022 $OGI
Organigram Holdings
Comp. Grant Buy 81,707 $1.23 $100K 70
Dec 17, 2020 $OGI
Organigram Holdings
Comp. Grant Buy 39,435 70
Muted rows are plan purchases, compensation grants, or DRIP — not open-market. Confluence Scores reflect the company's current score, not the score at time of trade.
Form55 provides data and analysis for informational purposes only. Nothing on this site constitutes investment advice or a recommendation to buy or sell any security. Past performance is not indicative of future results.